Agoracom Blog Home

Posts Tagged ‘CSE’

Kontrol $KNR.ca Provides COVID-19 Technology Update $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 9:09 AM on Wednesday, August 19th, 2020
kontrol-logo

Kontrol BioCloud®

  • Provides an update on the timing of the next stage of testing for the Kontrol BioCloud® analyzer
  • Kontrol has designed BioCloud with a replaceable detection mechanism. Kontrol will seek to patent the detection mechanism following the next stage of testing
  • Company will also analyze the best method of replacing and disposing of the detection mechanism after it comes into contact with COVID-19
  • The detection mechanism has been built to be an ongoing replaceable component of the BioCloud technology

TORONTO, ON / August 19, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to provide an update on the timing of the next stage of testing for the Kontrol BioCloud® analyzer (“BioCloud“).

For more than a decade, through its operating subsidiaries, Kontrol has been providing air quality testing and continuous emission monitoring across hundreds of industrial facilities in Canada and the USA. BioCloud represents an extension and further innovation of an existing air quality technology and solution platform which Kontrol currently provides to its customers.

“We are drawing on our extensive experience in air quality and emission monitoring for specific particulate analysis and measurement and using similar technology to detect for COVID-19 in the air,” says Paul Ghezzi, CEO of Kontrol. “Over the past 6 months, we have secured government funding, established partnerships with virology experts, and developed a proprietary COVID-19 detection chamber. Our initial lab results and interest from potential customers and prospects give us the confidence that we are developing a solution which the market demands. We look forward to providing more details as we continue BioCloud’s development.”

Next Stage of Testing

Live COVID-19 virus testing will commence on August 19th, 2020 and is expected to continue until the end of the month. The testing will focus on the capability of the working BioCloud prototype to sample the COVID-19 virus in aerosol form and seek to establish the lower detection limits that can be achieved. Kontrol will publish the results following the testing.

Detection Mechanism

Kontrol has designed BioCloud with a replaceable detection mechanism. Kontrol will seek to patent the detection mechanism following the next stage of testing. Kontrol will also analyze the best method of replacing and disposing of the detection mechanism after it comes into contact with COVID-19. The detection mechanism has been built to be an ongoing replaceable component of the BioCloud technology.

“BioCloud will seek to sample the air over-time on a continuous basis, which is similar to how we currently test for air quality in industrial facilities. Applications for BioCloud will be focused initially on classrooms, hospitals, long-term care homes, and mass transportation.” said Gary Saunders, Kontrol’s Vice President.

Pre-Commercialization Prototypes

Kontrol has built one operating prototype and is in the process of completing four additional pre-commercialization prototypes. These prototypes will be made available for lab testing and also provide Kontrol with greater certainty for developing its supply chain for parts and materials for potential future commercialization. The additional four prototypes will be completed prior to August 31st, 2020.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

About Kontrol Energy

Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.


Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.


For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

ImagineAR $IP $IPNFF Announces The Appointment of Gus Frerotte, Former NFL Pro Bowler QB, as Advisor For Augmented Reality Fan Engagement For Professional Sports $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:23 AM on Wednesday, August 19th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced that Gus Frerotte has joined the Company as an Advisor to the CEO for the purposes of marketing ImagineAR solutions to sports organizations to enhance fan engagement and generate new revenue streams
  • Mr. Frerotte is a former NFL Pro Bowler QB with over 15 years in the NFL league and current host of the podcast “Huddle with Gus”.
  • ImagineAR believes Gus will continue to accelerate the Company’s early Augmented Reality success within professional sports and related organizations.

VANCOUVER, BC and ERIE, PA, Aug. 19, 2020 – ImagineAR (CSE:IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports organizations, venues and brands to create their own mobile phone AR campaigns  is pleased to announce that Gus Frerotte has joined the Company as an Advisor to the CEO for the purposes of marketing ImagineAR solutions to sports organizations to enhance fan engagement and generate new revenue streams.   Mr. Frerotte is a former NFL Pro Bowler QB with over 15 years in the NFL league and current host of the podcast “Huddle with Gus”. ImagineAR believes Gus will continue to accelerate the Company’s early Augmented Reality success within professional sports and related organizations.

GUS FREROTTE PROFESSIONAL BACKGROUND

Mr. Frerotte stated, “After being introduced to ImagineAR while working with the Energy Innovation Center in Pittsburgh, I wanted to work directly with the company to bring a leading-edge Augmented Reality platform to the sports marketplace and related businesses to deliver fan engagement and activation.  ImagineAR has one of the most amazing mobile technologies I have seen to date and is even more important given the Covid-19 environment.  I am excited to be part of the ImagineAR team and extremely optimistic for our future success together.”

“Mr. Frerotte brings a tremendous track record of success in the NFL for over a decade and a significant professional network,” said Alen Paul Silverrstieen, CEO and President of Imagine AR. “With today’s paradigm shift in sports fan engagement due to Covid-19, Augmented Reality is a perfect activation technology for both in-stadium and live streaming at home.”

This press release is available on the Company’s AGORACOM Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

About Gus Frerotte

A 7th-round draft pick by the Washington Redskins, Gus went on to play QB for 7 different NFL teams–the Redskins, Detroit Lions, Denver Broncos, Cincinnati Bengals, Minnesota Vikings, Miami Dolphins, St. Louis Rams and Minnesota Vikings. His career highlights include an appearance in the 1996 Pro Bowl while with the Redskins and a 99-yard touchdown pass that tied the NFL record for the longest play from scrimmage for the Vikings. After a 15-year career in the NFL, Gus retired as a Minnesota Viking in 2008.

After his NFL career, Gus went on to coach at John Burroughs School from 2010-2013. During his three seasons, the Burroughs Bombers competed for the State Championship. He ended his high school coaching career with a record of 42-3. Upon moving back to Western Pennsylvania, Gus worked as a coach for the Pittsburgh Central Catholic Vikings from 2013 through 2016. After 15 years in the NFL, and raising three children who play contact sports, Gus is passionate about people taking care of their brain and has partnered with entrepreneurs making an impact in that sector. Transferring leadership skills learned from his professional sports career Gus is working with: RC21X, Winning Profile, Human Performance at The Energy Innovation Center and Huddle Up with Gus Podcast.

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO

(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if Imagination Park Entertainment Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR Inc. management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE ImagineAR

Avicanna $AVCN.ca Closes Non-Brokered Private Placement Raising $2.7 Million $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 4:51 PM on Tuesday, August 18th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • Closed a non-brokered private placement
  • Under the Offering, the Company has issued an aggregate of 1,952,410 units at a price of CAD$1.40 per Unit for aggregate gross proceeds of approximately CAD$2.7 million.

TORONTO, Aug. 18, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, is pleased to announce that it has closed a non-brokered private placement (the “Offering“). Under the Offering, the Company has issued an aggregate of 1,952,410 units (the “Units“) at a price of CAD$1.40 per Unit for aggregate gross proceeds of approximately CAD$2.7 million.

Setu Purohit, President of Avicanna commented, “We are very grateful for the continued support from our long-term and strategic investors who continue to demonstrate confidence in our business model and management team, especially in this challenging socio-economic environment. With this financing, we are able to strengthen our balance sheet, which coupled with our efforts to lower costs and see increase revenues gives us the bandwidth to continue to execute our business model.”

Each Unit is comprised of one (1) common share in the capital of the Company (each, a “Common Share“) and one-half of one (1/2) common share purchase warrant (each whole warrant, a “Warrant“). Each Warrant is exercisable into one common share in the capital of the Company (each, a “Warrant Share“) at a price of CAD$2.00 per Warrant Share until August 18, 2022, subject to the Company’s right to accelerate the expiry date of the Warrants on not less than thirty (30) days’ notice in the event that the volume weighted average trading price of the Common Shares exceeds CAD$3.00 for any ten (10) consecutive trading days on the Toronto Stock Exchange.

The Company intends to use the proceeds from the Offering for corporate development and general working capital purposes.

All securities issued under the Offering, including securities issuable on exercise thereof, are subject to a hold period expiring four months and one day from the date hereof. The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Toronto Stock Exchange.

The issuance and sale of 48,970 Units pursuant to the Offering to certain directors and officers of the Company constituted related party transactions within the meaning of Multilateral Instrument 61-101-Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1) (a) of MI 61-101, on the basis that the fair market value of the participation in the Offering by the insiders does not exceed 25% of the market capitalization of the Company, as determined in accordance with MI 61-101. The Company did not file a material change report in respect of the related party transaction at least 21 days before the closing of the Offering, which the Company deems reasonable in the circumstances so as to be able to avail itself of the proceeds of the Offering in an expeditious manner.

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura H&W: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the use of proceeds of the Offering. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

VIDEO – $KABN.ca Announces ~$3,000,000 Financing At 100% Premium With US Family Office and Foreign Investors $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 4:26 PM on Tuesday, August 18th, 2020
kabn-square-new

The headline pretty much speaks for itself this morning and it looks like the smallcap world is about to wake up to the FinTech potential of KABN.

What does KABN do that warrants such a significant financing at 100% premium to its’ closing price yesterday?

KABN Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models. 

Rather than trying to get you to understand what that exactly means by reading it here, be prepared to be blown away by KABN in this interview with Company President David Lucatch.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

HPQ Silicon $HPQ.ca and Pyrogenesis $PYR.ca Sign a Nano Silicon Development Agreement to Pursue Strong Industry Interest Generated by PUREVAP Nano Silicon Reactor $DUK $XEL $NEE

Posted by AGORACOM-JC at 1:13 PM on Tuesday, August 18th, 2020
  • Signed a development agreement covering the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) development program and the future commercialisation of nano silicon materials made with this new, proprietary and low cost manufacturing process
  • The process will transform Silicon (Si) into spherical Silicon nanopowders and nanowires for use in Li-ion batteries
  • Research indicates that replacing graphite with Nano Silicon (Si) Powders could allow the manufacturing of high-performance Li-ion batteries to deliver an almost tenfold (10x) increase in anode capacity, inducing a 20-40% gain in the energy density of the next generation of Li-Ion batteries

MONTREAL, Aug. 18, 2020 — HPQ Silicon Resources Inc.  (“HPQ” or the “Company”) TSX-V: HPQ; FWB: UGEOther OTC : URAGF; is pleased to announce that HPQ Nano Silicon Powders Inc (“HPQ NANO”), a 100% owned HPQ subsidiary, and PyroGenesis Canada Inc. (TSX-V: PYR) have signed a development agreement covering the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) development program and the future commercialisation of nano silicon materials made with this new, proprietary and low cost manufacturing process.  The process will transform Silicon (Si) into spherical Silicon nanopowders and nanowires for use in Li-ion batteries.

INDUSTRY INTEREST GENERATED FROM PREVIOUS ANNOUNCEMENTS NECESSITATE AGREEMENT 

On January 15, 2020 the Companies announced proof of concept testing demonstrating capacity to produce spherical nanopowders & nanowires from silicon (Si) needed by the Lithium-ion battery market.

That announcement was followed by an announcement on February 11, 2020 stating the Companies were developing NSiR for low-cost manufacturing of spherical Silicon (Si) nanopowders & nanowires for next generation Lithium-ion batteries.

As a result of these two announcements, strong and increasing industry interest in our project, even at this early stage of our development, dictates that HPQ and PyroGenesis take this next step.

INTEREST IN PUREVAPTM NSiR GAME CHANGING LOW COST POTENTIAL

Research indicates that replacing graphite with Nano Silicon (Si) Powders could allow the manufacturing of high-performance Li-ion batteries to deliver an almost tenfold (10x) increase in anode capacity, inducing a 20-40% gain in the energy density of the next generation of Li-Ion batteries. Silicon Nanomaterial potential to meet energy storage demand of the future is undeniable and is generating massive investments.

Despite the strong research and investment in Silicon nanomaterial, current manufacturing processes to make Nano Silicon powders are not scalable or commercially viable. HPQ and Pyrogenesis, via this agreement, are developing a process to address both the scalability and cost hurdles required by the industry.  

“The PUREVAPTM NSiR process was conceived and is being developed so that HPQ NANO can deliver to advanced materials companies and battery manufacturers a cost competitive, tailor-made product, that can replace graphite in batteries and thereby allow the deployment of truly powerful next generation Li-ion batteries.  Industry interest in our project is strong, even at this early stage of our development” said Bernard Tourillon, President & CEO of HPQ Silicon.  “This agreement allows us to devote all our efforts in a dedicated entity focussed on starting, as soon as possible, the PUREVAPTM NSiR and shipping samples of our Silicon nanomaterials.  Once the PUREVAPTM NSiR process is operational, expected to be in Q4 of 2020, HPQ NANO will implement the steps required to take full advantage of this unique multibillion-dollar business opportunity”.

“This Agreement represents another significant milestone in our relationship with HPQ. Battery storage is the future and it is indeed exciting for us to now be using our plasma expertise in addressing the challenges facing the lithium battery market,” said M. P Peter Pascali, President and CEO of PyroGenesis Canada Inc. “This milestone is also a testament to what can be achieved when two companies, and their Boards, work together with a common purpose and a clear understanding of the many unforeseen challenges in bringing such product lines to fruition.”

PROCESS VALIDATION AND IMPROVEMENT, NANO Si PRODUCTION & DEMONSTRATING SCALABILITY

The key areas covered by the agreement between HPQ NANO and PyroGenesis are:

  1. PUREVAPTM NSiR process development program, schedule and cost assumed by HPQ NANO;
  2. Acquisition of the PUREVAPTM NSiR Intellectual Property as it relates to the manufacturing of Nano Silicon powders and nanowires by HPQ NANO;
  3. Revenue distribution between HPQ NANO and PyroGenesis from the sales of Nano Silicon materials made with the PUREVAPTM NSiR.

The PUREVAPTM NSiR process development program is made of two distinct and complimentary phases, each with their own goals, timelines and milestones.

PHASE 1, VALIDATING AND IMPROVING THE PROCESS, MAKING SAMPLES BY END OF Q4 2020

The main goal of Phase 1 is modifying the existing Gen2 PUREVAPTM QRR reactor into the Gen1 NSiR for the purpose of producing nano silicon materials.  The resulting new Gen1 NSiR will be a batch process system with a design production capacity of 30 kg/month of nano silicon powders.  In order to meet the aggressive Phase 1 timeline agreed by the Parties, HPQ NANO will pay $200,000 to PyroGenesis over the next 15 weeks needed to complete the process engineering, mechanical engineering, fabrication and system commissioning.

Once the Gen1 NSiR is operational, as series of test runs will be done in order to produce nano Silicon materials.  In addition to producing samples for potential customers, the nano Silicon material produced will be analysed and characterized in order to define important process parameters, fine tune operating parameters and assess the performance of all the components of the systems.  HPQ NANO and PyroGenesis have agreed that each series of 10 tests would cost HPQ NANO $132,000.

PHASE 2, VALIDATING COMMERCIAL SCALABILITY, DELIVERING NANO SI MATERIALS

Phase 2 main objective is validating the commercial scalability of the PUREVAPTM NSiR.  Using data collected during Gen1 NSiR testing phase a completely new Gen2 NSiR system will be designed and built.  35 weeks will be needed to complete the process engineering, mechanical engineering, fabrication and system commissioning and HPQ NANO will pay $210,000 to PyroGenesis for this phase.

The Gen2 NSiR will be a semi-continuous process system with a design production capacity of 300 kg/month (or about 3,5 MT/year) of nano silicon powders or nanowires, giving HPQ NANO a large enough production capacity to be able to start selling nano silicon materials.  In addition to producing nano Silicon material, a series of Gen2 NSiR tests will be done to define the important process parameters and operating parameters required to allow the process and the systems to be scaled up to a commercial production capacity of about 2,500 MT of Nano-Silicon powders per year.

PUREVAPTM NSiR INTELLECTUAL PROPERTY AS IT RELATES TO NANO SILICON MATERIALS

The agreement also covers HPQ NANO acquisition of the intellectual property rights to the PUREVAP™ Nano Silicon (Si) Reactor process as it relates exclusively to the production of Micron size and Nano size Silicon Powders and Silicon Nanowires (the “Field”) from PyroGenesis. The acquisition cost of the PUREVAP™ NSiR IP is CAD$2,400,000 and HPQ NANO has 30 days from the effective date of the agreement to make the payment to PyroGenesis.

PyroGenesis will retain a royalty-free, exclusive, irrevocable worldwide license to use the process for purposes other than the production of Micron size and Nano size Silicon Powders and Silicon Nanowires.  Should PyroGenesis be approached by any other parties for any research and development or commercial purposes outside of the Field, HPQ NANO shall have a right of first refusal, provided that, however, HPQ NANO exercise its right of first refusal within thirty (30) days of PyroGenesis receiving a bona-fide offer.

NSIR REVENUES SPLIT BETWEEN HPQ NANO AND PYROGENESIS FROM SALES OF NANO SI MATERIALS

HPQ and PyroGenesis evaluated the short and long-term advantages of forming, at the start, a stand-alone joint venture responsible for manufacturing and selling Nanoscale Silicon (Si) powders.

A gradual approach was deemed more efficient, therefore HPQ Silicon created a fully own subsidiary, HPQ NANO Silicon Powders Inc, to be the stand-alone Corporation that would finance the Research and Development programs and manage the future commercialisation of Nanoscale Silicon (Si) materials made with the PUREVAPTM NSiR with PyroGenesis being granted the right to convert, at any time and at its sole discretion, it Royalty into a 50% equity stake in HPQ NANO.

As a result of this, HPQ NANO agrees to pay PyroGenesis, on an annual basis, and until conversion, the following minimum royalty (Nano-Royalty) on the gross sales of nano materials produced with the PUREVAPTM NSiR Process and Systems:

  • For 2021, the greater of 10% of HPQ NANO gross sales or fifty thousand dollars (CDN$50,000);
  • For 2022, the greater of 10% of HPQ NANO gross sales or one hundred thousand dollars (CDN$100,000);
  • For 2023, the greater of 10% of HPQ NANO gross sales or one hundred and fifty thousand dollars (CDN$150,000);
  • For 2024 and beyond, the greater of 10% of HPQ NANO gross sales or two hundred thousand dollars (CDN$200,000).

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way.  Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal,  building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
    • HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • The PUREVAPTM Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
    • HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
    • During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAPTM SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
    • The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
    • The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/2771b596-319e-4159-bfdf-35c6d04ed557

https://www.globenewswire.com/NewsRoom/AttachmentNg/6f635a97-9656-4d6f-8976-cd6468a98cb4
https://www.globenewswire.com/NewsRoom/AttachmentNg/18239f5c-0a59-41d6-a5c5-0f909ddd8687
IMAGE #1 PUREVAP NSiR Phase1 Tentative Timeline
Image 1): Indicative phase 1 project timelines
IMAGE #2 PUREVAP NSiR Phase2 Tentative Timeline
Image 2): Indicative phase 2 project timelines
Image #3 – PUREVAP NSiR Scaling Up
Image 3): Indicative scaling up pathway for PUREVAPTM NSiR

Source: GlobeNewswire (August 18, 2020 – 1:06 PM EDT)

News by QuoteMedia
www.quotemedia.com

VIDEO: Innocan Pharma $INNO.ca teams up with Endless Sky to manufacturer and distribute its #CBD products $WEED.ca $CL.ca $HEXO.ca

Posted by AGORACOM-JC at 12:11 PM on Tuesday, August 18th, 2020
Innocan-Blog
https://youtube.com/watch?v=leIG2iznw8g

Innocan Pharma Corporation (CSE:INNO) CEO Iris Bincovich and Endless Sky CEO Travis George tells Proactive the two have signed a manufacturing and distribution agreement.

Bincovich says Endless Sky will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its Health Canada-licensed facility in Redvers, Saskatchewan.

In exchange, ESI will pay Innocan Israel a fee per product in addition to royalties based on net sales.

Source: https://ca.proactiveinvestors.com/companies/news/926966/innocan-pharma-teams-up-with-endless-sky-to-manufacturer-and-distribute-its-cbd-products-926966.html

KABN NA $KABN.ca Receives Subscription Agreements for C$2,970,000 Investment at $0.33 CDN per Unit $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 11:31 AM on Tuesday, August 18th, 2020
kabn-square-new
  • Announced that it has received and accepted irrevocable subscriptions from a group of arm’s-length U.S. family office and foreign investors, for a total of 9 million common share units for gross proceeds of C$2,970,000
  • Each Unit is priced at C$0.33 per Unit.
  • Each Unit consists of one common share of the Company and ½ Common Share purchase warrant, with each whole Warrant entitling the holder to purchase one Common Share for C$0.37 per share for 24 months from closing of the transaction
  • “This agreement largely stems from the increasing recognition of Liquid Avatar as a potential game changer in the world of digital identity verification, management and monetization. We look forward to closing this financing over the next couple of weeks and continue to execute and deliver on our business programs,” said Ben Kessler, CEO – KABN North America

Toronto, Canada, August 18, 2020KABN Systems NA Holdings Corp.  (CSE:KABN) (the “Company” or “KABN” or “KABN North America”), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has received and accepted irrevocable subscriptions from a group of arm’s-length U.S. family office and foreign investors, for a total of 9 million common share units (“Units”) for gross proceeds of C$2,970,000. 

Each Unit is priced at C$0.33 per Unit. Each Unit consists of one common share of the Company (“Common Shares”) and ½ Common Share purchase warrant (“Warrants”), with each whole Warrant entitling the holder to purchase one Common Share for C$0.37 per share for 24 months from closing of the transaction.  No fees were paid in association with the financing.  In accordance with applicable securities rules and regulations, the Common Shares and the Warrants comprised in the Units, and the Common Shares issuable on exercise of the Warrants, will be subject to hold periods ranging from 4 months to 1 year, with the majority of the offering subject to a 1 year hold, restricting shares and warrants from transfer or trading except as permitted by law. 

“This agreement largely stems from the increasing recognition of Liquid Avatar as a potential game changer in the world of digital identity verification, management and monetization.  We look forward to closing this financing over the next couple of weeks and continue to execute and deliver on our business programs,” said Ben Kessler, CEO – KABN North America

The expected date of closing is on or before August 31, 2020, and may be extended by the Company.  The proceeds of the financing will provide working capital to further accelerate the Company’s development, customer acquisition and business platform consisting of Liquid Avatar, KABN ID, KABN KASH and KABN’s Visa Card program.

The KABN North American Fintech suite of products and services is comprised of:

Liquid Avatar allows users to create high quality digital icons representing their online personas.  These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want.  www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.  www.kabncard.com


KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

The Company welcomes the public to request an invitation to be an early adopter of Liquid Avatar and earn rewards at: https://liquidavatar.com/liquid-avatar-early-adopter/

About KABN North America – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:

Liquid Avatar allows users to create high quality digital icons representing their online personas.  These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want.  www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.  www.kabncard.com


KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

Ben Kessler

Chief Executive Officer

647-725-7742 Ext. 700

[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, including to accelerate the Company’s development, customer acquisition and business platform, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation.  Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Thoughtful Brands $TBI.ca Enters into Letters of Intent to Consider Acquisitions of Golden Path and Wild Mariposa $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-JC at 6:02 PM on Monday, August 17th, 2020
Throught-brands-logo-small
  • Entered into letters of intent with Golden Path LLC and Wild Mariposa LLC, pursuant to which it proposes to acquire all of the outstanding membership interests in both companies
  • Golden Path and Wild Mariposa are arms-length privately held companies involved in the online marketing and distribution of consumer health products

VANCOUVER, BC /  August 17, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1:GR)(OTCQB:PEMTF) (the “Company“) is pleased to announce that it has entered into letters of intent (collectively, the “Letters of Intent“), each dated August 17, 2020, with Golden Path LLC (“Golden Path“) and Wild Mariposa LLC (“Wild Mariposa“), pursuant to which it proposes to acquire all of the outstanding membership interests in both companies. Golden Path and Wild Mariposa are arms-length privately held companies involved in the online marketing and distribution of consumer health products.

Golden Path and Wild Mariposa are direct-to-consumer eCommerce brands selling a range of natural health products, including nutraceutical and hemp-based CBD products within the United States. Each product is carefully crafted based on market demand and product quality. Every product manufactured is third-party tested for purity and manufactured in the United States in GMP certified facilities. Both brands are current clients of Unified Funding, LLC which is contracted to perform a number of eCommerce business operations.

We are excited to look at the acquisition of these two established natural health brands as a further step in our eCommerce expansion in North America. Both brands possess product lines that are complimentary to Nature’s Exclusive and bring a large existing customer base along with nutraceutical product formulations and manufacturing relationships. Our timing is very strategic to acquire these brands as we near the closing of the Unified Funding asset acquisition, which will manage all go forward eCommerce operations for Thoughtful Brands”, stated Ryan Hoggan, CEO of the Company.

The Letters of Intent contemplate that the Company would acquire Golden Path, and Wild Mariposa, in consideration for the issuance of 11,544,400 common shares and 15,055,600 common shares (collectively, the “Consideration Shares“), respectively. The Consideration Shares will be issued to the existing members of Golden Path, and Wild Mariposa, at a deemed price of Cdn$0.195 per share.

The Company is at arms-length from each of Golden Path, Wild Mariposa and their respective members. The transactions contemplated by the Letters of Intent do not constitute a fundamental change for the company, nor are they expected to result in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. The transactions are contingent upon each other, and the Company does not intend to proceed with the transactions unless both can be completed concurrently. Upon completion of the transactions, an administrative fee of 266,000 common shares of the Company will be owing to a consultant who assisted with the transactions.

The transactions remain subject to a number of conditions, including completion of due diligence, receipt of any required regulatory approval and the negotiation of definitive documentation, which is expected to include warranties, representations, covenants, terms and conditions which are customary and consistent with industry standards for transactions of this nature. The transactions cannot be completed until these conditions have been satisfied.

About Thoughtful Brands Inc.

Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

ON BEHALF OF THE BOARD OF DIRECTORS

THOUGHTFUL BRANDS INC.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to its plans to acquire Golden Path and Wild Mariposa, along with additional revenue-producing natural health product brands and operations in both Europe and North America with the goal of establishing an international distribution network utilizing its eCommerce technology platform. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Thoughtful Brands Inc.

#Nickel hits highest in nearly 9 months on Philippine supply concerns SPONSOR Tartisan #Nickel $TN.ca $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 5:48 PM on Monday, August 17th, 2020

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including an equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

Nickel hits highest in nearly 9 months on Philippine supply concerns

  • Nickel prices surged to their highest in nearly nine months on Monday on concern over supply from the Philippines, the leading exporter of the stainless steel raw material
  • Copper and most other industrial metals also pushed higher after the central bank of top commodities consumer China injected fresh funds into the financial system

(Updates with official prices) By Eric Onstad LONDON, Aug 17 (Reuters) – Nickel prices surged to their highest in nearly nine months on Monday on concern over supply from the Philippines, the leading exporter of the stainless steel raw material. Copper and most other industrial metals also pushed higher after the central bank of top commodities consumer China injected fresh funds into the financial system. “This remains a liquidity-driven market. Most investors are still expecting the Chinese economy to perform well in the future, so they see good reason to stick to the bullish side of the market,” said Gianclaudio Torlizzi, a partner at Milan consultancy T-Commodity. Three-month nickel on the London Metal Exchange (LME) climbed 1.6% to $14,602 a tonne in official trading after hitting $14,665, its strongest since Nov. 25. Nickel ore output from the Philippines, the world’s biggest exporter of the material, dropped 28% year on year to 102,310 tonnes by metal content over January-June, data showed.
* Also supporting nickel were strong ShFE stainless steel futures , which climbed as much as 4.2% to 14,775 yuan a tonne. Most nickel is used as an alloy to make stainless steel.
* Nickel ore prices at Philippine ports were hovering at their highest in eight and a half months at $10.25 a tonne, data from metals prices provider SMM showed.
* LME copper advanced 1% to $6,428 a tonne, though T-Commodity’s Torlizzi was wary of the strong recent gains that have lifted the price by 47% since March and prompted him to take a short position. “We think the risk of being long here is high and is very vulnerable to disappointment.”
* LME copper stocks sank to their lowest levels in more than 12 years to 110,000 tonnes.

* LME zinc jumped 2.4% in official activity to its highest in nearly seven months at $2,423.50 a tonne as aluminium rose 0.6% to $1,757. Lead gained 1.2% to $1,973.50, its strongest since Jan. 23, but tin shed 1% to $17,426.
* For the top stories in metals and other news, click or . ($1 = 6.9382 yuan) (Additional reporting by Mai Nguyen Editing by Jan Harvey and David Goodman)

Source: https://www.kitco.com/news/2020-08-17/METALS-Nickel-hits-highest-in-nearly-9-months-on-Philippine-supply-concerns.html

#Mhealth Market Sets the Table for Continued Growth – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 5:38 PM on Monday, August 17th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Mhealth Apps Market 2020 Sets the Table for Continued Growth

Global mHealth Applications Market — overview

The Global mHealth applications market is growing with a rapid pace. According to a recent study report published by the Market Research Future, the Global mHealth applications market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace. The market is projected to demonstrate a sound growth by 2023, surpassing its previous growth records in terms of value with a sound CAGR during the anticipated period (2017–2023).

Global mHealth Applications Market — regional analysis

The global mHealth Apps Marketis segmented into four different regions namely; North America, Europe, Asia-Pacific (APAC), and Middle East and Africa (ME&A). High-income countries were reported highest adoption of mHealth and people from these countries are actively using mHealth services. The market form mHealth applications is growing rapidly in developing countries such as China and India. According to International Telecommunication Union, the number of mobile phone subscription is reached to about 5 billion throughout the world and about 70% of them are in low-middle income countries.

Technology is transforming the entire world and healthcare is not exception for it. Digital innovation and technological advancement is helping to put healthcare to the next level. After the evolution of the term called eHealth, now it is the era of mHealth. mHealth commonly known as mobile health. Use of mHealth devices and mobile devices is growing at tremendous rate throughout the globe and technology is changing dramatically. mHealth has potential to change the healthcare sector and can make is more accessible, affordable and faster. Technology is the major driving force behind the mHealth.

Technological advancement is providing better healthcare solution that changing the way of medical sector. Continuous innovation is most influencing force in this market. The demand for advanced and innovative products are increasing at rapid pace. Introduction of innovative product in the market gives first mover advantage to the solution provider. Options of better treatments, access to the solutions, improved affordability and convenience are changing the healthcare sector. Many times mHealth changes the traditional healthcare like, healthcare professionals can directly connect and assist patients from thousand miles away through mHealth technology. However, factors such as security and confidentiality threats along with resistance to change and market volatility are the major restraining factors for the market growth, during the forecast period.

Read More: https://medium.com/healthandhealthcareresearchreports/mhealth-apps-market-2020-sets-the-table-for-continued-growth-global-players-2e6bad48733f